Altshuler Shaham’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,376
Closed -$1.09M 385
2024
Q3
$1.09M Sell
38,376
-7,500
-16% -$193K 0.07% 47
2024
Q2
$877K Hold
45,876
0.03% 51
2024
Q1
$1.5M Buy
45,876
+5,267
+13% +$168K 0.06% 35
2023
Q4
$1.34M Buy
40,609
+25,609
+171% +$725K 0.07% 32
2023
Q3
$408K Buy
15,000
+3,000
+25% +$83.4K 0.01% 70
2023
Q2
$364K Buy
+12,000
New +$388K 0.01% 82
2022
Q4
Sell
-694
Closed -$25K 508
2022
Q3
$25K Buy
+694
New +$24.4K ﹤0.01% 355

Other funds holding EVH

Altshuler Shaham's EVH Position: Q4 2024 in Review

Altshuler Shaham sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 38,376 shares — an estimated $1.09M sold.

Altshuler Shaham first reported a position in EVH in Q3 2022 and held it in 7 quarters. The position peaked at $1.5M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Altshuler Shaham reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Altshuler Shaham sold 38,376 Evolent Health shares in Q4 2024, an estimated $1.09M.
  • Altshuler Shaham first reported a position in Evolent Health in Q3 2022 and held it in 7 quarters.
  • Altshuler Shaham's Evolent Health position peaked at $1.5M in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Altshuler Shaham's 13F filing for Q4 2024, filed 13 Feb 2025.